These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4058469)

  • 1. Measurement of junctional acetylcholine receptors in myasthenia gravis: clinical correlates.
    Pestronk A; Drachman DB; Self SG
    Muscle Nerve; 1985; 8(3):245-51. PubMed ID: 4058469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymyositis: reduction of acetylcholine receptors in skeletal muscle.
    Pestronk A; Drachman DB
    Muscle Nerve; 1985; 8(3):233-9. PubMed ID: 4058467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromuscular junction in myasthenia gravis: decreased acetylcholine receptors.
    Fambrough DM; Drachman DB; Satyamurti S
    Science; 1973 Oct; 182(4109):293-5. PubMed ID: 4742736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.
    Elias SB; Appel SH
    Ann Neurol; 1978 Sep; 4(3):250-2. PubMed ID: 718136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pathophysiology of penicillamine-induced myasthenia gravis.
    Kuncl RW; Pestronk A; Drachman DB; Rechthand E
    Ann Neurol; 1986 Dec; 20(6):740-4. PubMed ID: 3813503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.
    Ashizawa T; Elias SB; Appel SH
    Ann Neurol; 1982 Jan; 11(1):22-7. PubMed ID: 6277235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of postsynaptic plasticity: remodeling of the junctional acetylcholine receptor cluster induced by motor nerve terminal outgrowth.
    Yee WC; Pestronk A
    J Neurosci; 1987 Jul; 7(7):2019-24. PubMed ID: 3302123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Congenital myasthenia: end-plate acetylcholine receptors and electrophysiology in five cases.
    Vincent A; Cull-Candy SG; Newsom-Davis J; Trautmann A; Molenaar PC; Polak RL
    Muscle Nerve; 1981; 4(4):306-18. PubMed ID: 7254233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3-Deazaadenosine: a therapeutic strategy for myasthenia gravis by decreasing the endocytosis of acetylcholine receptors.
    Kuncl RW; Drachman DB; Adams R; Lehar M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):582-9. PubMed ID: 8246131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A myasthenia gravis plasma immunoglobulin reduces miniature endplate potentials at human endplates in vitro.
    Burges J; Wray DW; Pizzighella S; Hall Z; Vincent A
    Muscle Nerve; 1990 May; 13(5):407-13. PubMed ID: 2345558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-immunogenic myasthenia gravis model and its application in a study of transsynaptic regulation at the neuromuscular junction.
    Molenaar PC; Oen BS; Plomp JJ; Van Kempen GT; Jennekens FG; Hesselmans LF
    Eur J Pharmacol; 1991 Apr; 196(1):93-101. PubMed ID: 1874282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of myasthenic IgG on degradation of junctional acetylcholine receptor.
    Takeo G; Motomura M; Mats H; Ohishi K; Yoshimura T; Tsujihata M; Nagataki S
    Muscle Nerve; 1993 Aug; 16(8):840-8. PubMed ID: 8332137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different degradation rates of junctional and extrajunctional acetylcholine receptors of human muscle cultured in monolayer and innervated by fetal rat spinal cord neurons.
    Braun S; Askanas V; Engel WK
    Int J Dev Neurosci; 1992; 10(1):37-44. PubMed ID: 1609620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acetylcholine release in myasthenia gravis: regulation at single end-plate level.
    Plomp JJ; Van Kempen GT; De Baets MB; Graus YM; Kuks JB; Molenaar PC
    Ann Neurol; 1995 May; 37(5):627-36. PubMed ID: 7755358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in neuromuscular junction structure in dystrophic muscle are corrected by expression of a NOS transgene in dystrophin-deficient muscles, but not in muscles lacking alpha- and beta1-syntrophins.
    Shiao T; Fond A; Deng B; Wehling-Henricks M; Adams ME; Froehner SC; Tidball JG
    Hum Mol Genet; 2004 Sep; 13(17):1873-84. PubMed ID: 15238508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired slow-channel syndrome: a form of myasthenia gravis with prolonged open time of the acetylcholine receptor channel.
    Wintzen AR; Plomp JJ; Molenaar PC; van Dijk JG; van Kempen GT; Vos RM; Wokke JH; Vincent A
    Ann Neurol; 1998 Oct; 44(4):657-64. PubMed ID: 9778265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo imaging shows loss of synaptic sites from neuromuscular junctions in a model of myasthenia gravis.
    Rich MM; Colman H; Lichtman JW
    Neurology; 1994 Nov; 44(11):2138-45. PubMed ID: 7969973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Passive transfer of seronegative myasthenia gravis to mice.
    Burges J; Vincent A; Molenaar PC; Newsom-Davis J; Peers C; Wray D
    Muscle Nerve; 1994 Dec; 17(12):1393-400. PubMed ID: 7969240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired canine myasthenia gravis: immunocytochemical localization of immune complexes at neuromuscular junctions.
    Pflugfelder CM; Cardinet GH; Lutz H; Holliday TA; Hansen RJ
    Muscle Nerve; 1981; 4(4):289-95. PubMed ID: 7019698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C Histomorphology of neuromuscular junction in Duchenne muscular dystrophy.
    Theroux MC; Olivant A; Akins RE
    Paediatr Anaesth; 2008 Mar; 18(3):256-9. PubMed ID: 18230070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.